Tajikistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Tajikistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 0.9% year on year. In 2019, the country was ranked number 48 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 944 Cases. Tajikistan is overtaken by Democratic Republic of the Congo, which was number 47 with 960 Cases and is followed by Moldova with 924 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 944.00 |
| 2018 | 916.00 |
| 2017 | 936.00 |
| 2016 | 748.00 |
| 2015 | 675.00 |
How does Tajikistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 47 |
#47
Democratic Republic of the Congo
|
960 | 2019 | +6.9 % | +16.8 % | View data | |
| 48 |
#48
Tajikistan
|
944 | 2019 | +3.1 % | +0.9 % | View data | |
| 49 |
#49
Moldova
|
924 | 2019 | +0.5 % | -0.0 % | View data | |